Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 2Phase 2 2Phase 1 2Phase 4 1

Status

Unknown 2Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 1Endometrial Neoplasms 1

Interventions

fludarabine 17Cyclophosphamide 16Positron Emission Tomography Computed Tomography 4Oncolytic Virotherapy 4Metformin 468Ga-pentixafor 4lenvatinib 3Radiosurgery 3Pemetrexed 3Paclitaxel 3Melphalan 3Immunotherapy, Adoptive 3Gemcitabine 3Cholestanetriol 26-Monooxygenase 3Carboplatin 3toripalimab 2sintilimab 2pembrolizumab 2gallium Ga 68 dotatate 2gallium 68 PSMA-11 2fludarabine phosphate 2alpha-Synuclein 2Progesterone 2Nivolumab 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Influenza Vaccines 2Fluorodeoxyglucose F18 2Ethiodized Oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Progesterone × Clear all
NCT04597099 2023-11-02

CRM010

University of Virginia

Phase EARLY_PHASE1 Unknown
10 enrolled

Polycystic Ovary Syndrome

NCT04046185 2019-08-06

ECCT

Shanghai First Maternity and Infant Hospital

Phase EARLY_PHASE1 Unknown
60 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡